← Back to Screener
Bruker Corporation (BRKR)
Price$41.10
Favorite Metrics
Price vs S&P 500 (26W)6.55%
Price vs S&P 500 (4W)9.76%
Market Capitalization$6.23B
Indicated Dividend Yield (Annual)0.49%
All Metrics
P/CF (Annual)46.37x
Book Value / Share (Quarterly)$16.15
P/TBV (Annual)4.60x
Indicated Dividend (Annual)$0.20
Revenue Growth (3Y)10.74%
Cash Flow / Share (Quarterly)$0.09
Payout Ratio (TTM)64.51%
Price vs S&P 500 (YTD)-16.69%
Gross Margin (TTM)47.13%
Net Profit Margin (TTM)-0.25%
EPS (TTM)$-0.06
10-Day Avg Trading Volume1.86M
EPS Excl Extra (TTM)$-0.06
Revenue Growth (5Y)11.57%
EPS (Annual)$-0.06
Dividend / Share (Annual)$0.22
ROI (Annual)-0.20%
Gross Margin (Annual)47.13%
Net Profit Margin (5Y Avg)8.14%
Cash / Share (Quarterly)$1.96
Revenue Growth QoQ (YoY)-0.24%
ROA (Last FY)-0.14%
Revenue Growth TTM (YoY)2.08%
EBITD / Share (TTM)$1.79
ROE (5Y Avg)17.91%
Operating Margin (TTM)1.40%
Cash Flow / Share (Annual)$0.09
P/B Ratio2.54x
P/B Ratio (Quarterly)2.91x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)2.27x
Net Interest Coverage (TTM)1.75x
ROA (TTM)-0.14%
EPS Growth QoQ (YoY)89.47%
EV / EBITDA (TTM)28.74x
EPS Incl Extra (Annual)$-0.06
Current Ratio (Annual)1.73x
Quick Ratio (Quarterly)0.83x
3-Month Avg Trading Volume2.24M
52-Week Price Return13.29%
EV / Free Cash Flow (Annual)549.50x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$10.23
P/S Ratio (Annual)1.81x
Asset Turnover (Annual)0.55x
52-Week High$56.22
Operating Margin (5Y Avg)12.22%
EPS Excl Extra (Annual)$-0.06
CapEx CAGR (5Y)4.34%
Tangible BV CAGR (5Y)16.29%
26-Week Price Return13.44%
Quick Ratio (Annual)0.83x
13-Week Price Return-16.90%
Total Debt / Equity (Annual)0.76x
Current Ratio (Quarterly)1.73x
Enterprise Value$7,802.918
Revenue / Share Growth (5Y)11.98%
Asset Turnover (TTM)0.55x
Book Value / Share Growth (5Y)20.62%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)1.64x
Pretax Margin (Annual)0.64%
Cash / Share (Annual)$1.96
3-Month Return Std Dev47.38%
Gross Margin (5Y Avg)49.86%
Net Income / Employee (TTM)$-0
EBITDA CAGR (5Y)-3.56%
EBITDA Interim CAGR (5Y)-0.38%
ROE (Last FY)-0.35%
Net Interest Coverage (Annual)1.75x
EPS Basic Excl Extra (Annual)$-0.06
P/FCF (TTM)28.71x
Receivables Turnover (TTM)5.22x
EV / Free Cash Flow (TTM)549.50x
Total Debt / Equity (Quarterly)0.76x
EPS Incl Extra (TTM)$-0.06
Receivables Turnover (Annual)5.22x
ROI (TTM)-0.20%
Dividend Growth Rate (5Y)6.15%
P/S Ratio (TTM)1.81x
Pretax Margin (5Y Avg)11.56%
Revenue / Share (Annual)$22.64
Tangible BV / Share (Annual)$10.23
Forward P/E19.44x
Free OCF CAGR (5Y)-42.95%
Price vs S&P 500 (52W)-21.35%
Year-to-Date Return-12.76%
5-Day Price Return3.01%
EPS Normalized (Annual)$-0.06
ROA (5Y Avg)5.53%
Net Profit Margin (Annual)-0.25%
Month-to-Date Return13.79%
Cash Flow / Share (TTM)$2.86
EBITD / Share (Annual)$1.79
Operating Margin (Annual)1.40%
LT Debt / Equity (Annual)0.75x
P/CF (TTM)46.37x
ROI (5Y Avg)8.60%
LT Debt / Equity (Quarterly)0.75x
EPS Basic Excl Extra (TTM)$-0.06
P/TBV (Quarterly)4.60x
Payout Ratio (Annual)26.70%
P/B Ratio (Annual)2.91x
Dividend / Share (TTM)$0.22
Inventory Turnover (TTM)1.64x
Pretax Margin (TTM)0.64%
Book Value / Share (Annual)$16.15
Price vs S&P 500 (13W)-19.28%
Dividend Yield (TTM)0.53%
Beta1.22x
P/FCF (Annual)438.92x
Revenue / Share (TTM)$22.59
ROE (TTM)-0.40%
52-Week Low$28.53
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.95
3.95
3.95
3.95
Industry Peers — Lab Analytical Instruments(22)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
BRKRBruker Corporation | 1.81x | 11.57% | 47.13% | 1.40% | $41.10 |
AAgilent Technologies Inc. | 4.83x | 5.41% | 52.60% | 20.40% | $120.96 |
WATWaters Corp | 10.18x | 6.00% | 59.28% | 25.36% | $335.61 |
MTDMettler-Toledo International | 6.66x | 5.47% | 59.37% | 26.05% | $1324.66 |
ILMNIllumina Inc | 4.69x | 6.04% | 66.61% | 18.44% | $132.86 |
RVTYRevvity, Inc. | 3.64x | -5.46% | 54.77% | 12.49% | $93.03 |
BIOBio-Rad Laboratories, Inc.Class A | 3.17x | 0.29% | 52.01% | 1.59% | $303.34 |
BIO.BBio-Rad Laboratories, Inc. Class B | 3.17x | 0.29% | 52.01% | 1.59% | $277.00 |
BRKRPBruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A | 1.81x | 11.57% | 47.13% | 1.40% | $320.13 |
AVTRAvantor, Inc. | 0.88x | 0.49% | 32.65% | -3.83% | $8.50 |
TXG10x Genomics, Inc. Class A Common Stock | 5.18x | 16.56% | 69.13% | -9.49% | $24.59 |
About
Bruker Corporation manufactures scientific instruments and diagnostic tests serving the life sciences, pharmaceutical, and biotechnology industries. The company operates through multiple segments, including BioSpin, CALID, and Nano divisions, with CALID generating the largest revenue contribution. The majority of its revenue is derived from the United States market.